Data / Form D filings / AssayQuant Technologies, Inc.
AssayQuant Technologies, Inc.: Form D filings
AssayQuant Technologies, Inc., a biotechnology company in Marlboro, MD, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on July 25, 2023, reports $5.1 million sold of a $12 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 260 CEDAR HILL STREET, Marlboro, MD, 01752
- Phone
- (774) 278-4797
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1861955
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2023 | Amendment | $12,000,000 | $5,122,385 | $6,877,615 | 21 | Jul 7, 2023 | sec.gov |
| Jul 10, 2023 | New notice | $12,000,000 | $5,122,385 | $6,877,615 | 21 | Jul 7, 2023 | sec.gov |
| May 14, 2021 | New notice | $4,500,000 | $4,500,000 | 9 | May 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Barbara Imperiali | Director | |
| Gil Price | Director | |
| Jeffrey Hoerle | Director | |
| Erik Schaefer | Executive Officer | |
| Charles Baltic | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jul 24, 2023 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AssayQuant Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.